Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
24.18
+1.62 (7.18%)
At close: Jul 30, 2026, 4:00 PM EDT
24.31
+0.13 (0.54%)
After-hours: Jul 30, 2026, 5:01 PM EDT

Adaptive Biotechnologies Operating Metrics

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Number of Clonoseq Tests Delivered
125.86K115.07K105.59K96.49K88.98K82.18K76.11K70.84K
Number of Clonoseq Tests Delivered Growth
41.44%40.01%38.74%36.21%34.19%33.72%34.71%37.98%

Revenue by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
MRD
251.94M235.71M212.33M190.60M171.28M156.62M145.53M136.14M
MRD Growth
47.09%50.49%45.90%40.00%38.87%37.46%41.65%36.03%
Immune Medicine
56.15M59.70M64.64M62.16M33.94M32.90M33.43M41.14M
Immune Medicine Growth
65.43%81.45%93.38%51.09%-25.29%-45.67%-50.50%-48.32%

Immune Medicine Revenue Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Collaboration
37.68M41.28M44.78M14.55M12.36M13.45M17.87M22.37M----
Collaboration Growth
204.77%206.88%150.58%-34.98%-67.59%-68.41%-64.93%-65.19%----
Immune Medicine Service
22.02M23.36M17.38M19.39M20.54M19.98M23.27M23.06M----
Immune Medicine Service Growth
7.21%16.94%-25.31%-15.89%-8.37%-19.96%-18.79%-23.09%----

Adjusted EBITDA by Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
MRD
31.44M15.19M-1.79M-14.87M-28.08M-41.22M----------------
Immune
4.24M9.16M5.36M-23.56M-24.52M-26.01M----------------

MRD Revenue Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Service
211.71M192.83M174.10M156.28M144.12M133.03M123.64M115.84M----
Service Growth
46.89%44.96%40.81%34.91%31.69%29.48%26.06%24.07%----
Regulatory Milestone
24.00M19.50M16.50M15.00M12.50M12.50M12.50M7.50M----
Regulatory Milestone Growth
92.00%56.00%32.00%100.00%177.78%-525.00%275.00%----